84 related articles for article (PubMed ID: 9089630)
1. Refolding of soluble leukemia inhibitory factor receptor fusion protein (gp 190 sol DAF) from urea.
Liu H; Moreau JF; Gualde N; Fu J
Mol Cell Biochem; 1997 Apr; 169(1-2):43-50. PubMed ID: 9089630
[TBL] [Abstract][Full Text] [Related]
2. Inter-species chimeras of leukemia inhibitory factor define a human receptor binding site.
Owczarek CM; Layton MJ; Metcalf D; Clark R; Gough NM; Nicola NA
Ann N Y Acad Sci; 1995 Jul; 762():165-78. PubMed ID: 7668527
[No Abstract] [Full Text] [Related]
3. The soluble interleukin-6 receptor.
Rose-John S; Ehlers M; Grötzinger J; Müllberg J
Ann N Y Acad Sci; 1995 Jul; 762():207-20; discussion 220-1. PubMed ID: 7668529
[No Abstract] [Full Text] [Related]
4. Involving of the cytoplasmic region of leukemia inhibitory factor receptor alpha subunit, IL-6 related signal transducer-gp130 or fas death domain for MAPK p42/44 activation in HL-60 cell with LIF or anti-Fas IgG.
Liu H; Dan J; Tang S; Wu S
Mol Cell Biochem; 2001 Jan; 217(1-2):113-20. PubMed ID: 11269654
[TBL] [Abstract][Full Text] [Related]
5. Molecular cloning and functional expression of mouse cDNAs encoding the membrane receptor and the soluble receptor for D-factor/LIF.
Tomida M
Ann N Y Acad Sci; 1995 Jul; 762():480-1. PubMed ID: 7668564
[No Abstract] [Full Text] [Related]
6. The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex.
Aasland D; Oppmann B; Grötzinger J; Rose-John S; Kallen KJ
J Mol Biol; 2002 Jan; 315(4):637-46. PubMed ID: 11812136
[TBL] [Abstract][Full Text] [Related]
7. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.
Terstegen L; Maassen BG; Radtke S; Behrmann I; Schaper F; Heinrich PC; Graeve L; Gatsios P
FEBS Lett; 2000 Jul; 478(1-2):100-4. PubMed ID: 10922477
[TBL] [Abstract][Full Text] [Related]
8. Oncostatin M binds the high-affinity leukemia inhibitory factor receptor.
Gearing DP; Bruce AG
New Biol; 1992 Jan; 4(1):61-5. PubMed ID: 1536831
[TBL] [Abstract][Full Text] [Related]
9. Structure of the mouse leukaemia inhibitory factor receptor gene: regulated expression of mRNA encoding a soluble receptor isoform from an alternative 5' untranslated region.
Chambers I; Cozens A; Broadbent J; Robertson M; Lee M; Li M; Smith A
Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):879-88. PubMed ID: 9396734
[TBL] [Abstract][Full Text] [Related]
10. Proliferative responses and binding properties of hematopoietic cells transfected with low-affinity receptors for leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor.
Gearing DP; Ziegler SF; Comeau MR; Friend D; Thoma B; Cosman D; Park L; Mosley B
Proc Natl Acad Sci U S A; 1994 Feb; 91(3):1119-23. PubMed ID: 8302840
[TBL] [Abstract][Full Text] [Related]
11. [Function, molecular structure and gene expression regulation of receptor for D-factor/LIF].
Tomida M
Nihon Rinsho; 1992 Aug; 50(8):1956-61. PubMed ID: 1433987
[TBL] [Abstract][Full Text] [Related]
12. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
[TBL] [Abstract][Full Text] [Related]
13. The crystal structure and biological function of leukemia inhibitory factor: implications for receptor binding.
Robinson RC; Grey LM; Staunton D; Vankelecom H; Vernallis AB; Moreau JF; Stuart DI; Heath JK; Jones EY
Cell; 1994 Jul; 77(7):1101-16. PubMed ID: 8020098
[TBL] [Abstract][Full Text] [Related]
14. Analysis of recombinant soluble mouse D-factor/LIF receptor.
Tomida M
J Biochem; 1995 Jun; 117(6):1228-31. PubMed ID: 7490264
[TBL] [Abstract][Full Text] [Related]
15. Structural and functional studies on the leukemia inhibitory factor receptor (LIF-R): gene and soluble form of LIF-R, and cytoplasmic domain of LIF-R required for differentiation and growth arrest of myeloid leukemic cells.
Tomida M
Leuk Lymphoma; 2000 May; 37(5-6):517-25. PubMed ID: 11042511
[TBL] [Abstract][Full Text] [Related]
16. Binding interactions of leukemia inhibitory factor and ciliary neurotrophic factor with the different subunits of their high affinity receptors.
Robledo O; Auguste P; Coupey L; Praloran V; Chevalier S; Pouplard A; Gascan H
J Neurochem; 1996 Apr; 66(4):1391-9. PubMed ID: 8627290
[TBL] [Abstract][Full Text] [Related]
17. [Leukemia inhibitory factor and its physiological functions during embryo development and blastocyst implantation].
Zhang CY; Duan EK; Zeng GQ
Sheng Li Ke Xue Jin Zhan; 1997 Jul; 28(3):240-2. PubMed ID: 11038733
[No Abstract] [Full Text] [Related]
18. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
[TBL] [Abstract][Full Text] [Related]
19. Soluble glycoprotein 130 (gp130) attenuates OSM- and LIF-induced cartilage proteoglycan catabolism.
Hui W; Bell M; Carroll G
Cytokine; 2000 Feb; 12(2):151-5. PubMed ID: 10671300
[TBL] [Abstract][Full Text] [Related]
20. Chimeric cytokine receptor can transduce expansion signals in interleukin 6 receptor alpha (IL-6Ralpha)-, IL-11Ralpha-, and gp130-low to -negative primitive hematopoietic progenitors.
Takagi M; Nakamura T; Sawada T; Kaneko A; Nozaki-Ukai M; Nakahata T; Yokota T; Heike T
Mol Biol Cell; 1999 Nov; 10(11):3633-42. PubMed ID: 10564261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
